Purple Biotech Appoints Lior Fhima as Chief Financial Officer

(marketscreener.com) Seasoned financial executive strengthens management team  REHOVOT, Israel, Nov. 02, 2022 -- Purple Biotech Ltd. , a clinical-stage company developing first-in-class, effective and durable therapies by harnessing the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced the appointment...https://www.marketscreener.com/quote/stock/PURPLE-BIOTECH-LTD-24978833/news/Purple-Biotech-Appoints-Lior-Fhima-as-Chief-Financial-Officer-42176902/?utm_medium=RSS&utm_content=20221102